Dna Group (T.R.) Ltd (TLV:DNA)
112.90
+3.70 (3.39%)
Jul 31, 2025, 5:24 PM IDT
Dna Group (T.R.) Market Cap
Dna Group (T.R.) has a market cap or net worth of 137.94 million as of August 1, 2025. Its market cap has increased by 58.19% in one year.
Market Cap
137.94M
Enterprise Value
69.63M
Revenue
306.00K
Ranking
n/a
PE Ratio
6.26
Stock Price
112.90
Market Cap Chart
Since December 3, 2007, Dna Group (T.R.)'s market cap has increased from 31.81M to 137.94M, an increase of 333.61%. That is a compound annual growth rate of 8.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 137.94M | 23.35% |
Dec 31, 2024 | 111.83M | 43.67% |
Dec 31, 2023 | 77.84M | -10.57% |
Dec 29, 2022 | 87.04M | -44.63% |
Dec 30, 2021 | 157.19M | 586.31% |
Dec 31, 2020 | 22.90M | 11.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 60.21B |
Danel (Adir Yeoshua) | 2.76B |
Kamada | 1.46B |
Bait Bakfar | 1.12B |
SofWave Medical | 884.68M |
BrainsWay | 757.07M |
Novolog (Pharm-Up 1966) | 710.12M |
Ilex Medical | 675.20M |